Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Originally characterized at the University of Florida by the Stephen ORahilly and Robert Kraft groups, the compound has been studied in preclinical research for body composition, adipose tissue lipolysis, glucose homeostasis, skeletal muscle aging, and metabolic disease endpoints
Contraindicated for use in clients with liver and kidney insufficiency and those who are breastfeeding or pregnant
Improved Insulin Sensitivity: Enhances glucose metabolism and may support blood sugar regulation, making it a potential tool in managing metabolic syndrome and type 2 diabetes
The side-effect dataset is preclinical only
You might need to change your dose if your symptoms dont get better or if lab results show youre not getting enough B12
US$ 23.37
US$ 26.67
US$ 21.29
US$ 21.96
